Allecra Therapeutics: Advanz Pharma receives positive CHMP opinion for Exblifep (cefepime/enmetazobactam) to treat complicated urinary tract infections,

Advanz Holdco Limited a UK headquartered global pharmaceutical company announced that the CHMP has adopted a positive opinion and recommended granting a marketing authorization for Exblifep, an antibiotic fixed-dose combination of cefepime and enmetazobactam.